Search details
1.
Epidemiology of Huntington's Disease in the United States Medicare and Medicaid Populations.
Neuroepidemiology
; 56(3): 192-200, 2022.
Article
in English
| MEDLINE | ID: mdl-35483335
2.
Prevalence and Characteristics of Pediatric Opioid Exposures and Poisonings in the United States.
J Pediatr
; 206: 148-155.e4, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30612813
3.
Assessing patient and caregiver preferences for treatment of haemophilia A: A discrete choice experiment.
Haemophilia
; 27(4): e479-e483, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33215806
4.
Healthcare utilization and direct medical costs of Huntington's disease among Medicaid beneficiaries in the United States.
J Med Econ
; 26(1): 811-820, 2023.
Article
in English
| MEDLINE | ID: mdl-37285853
5.
Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis.
Adv Ther
; 40(3): 903-919, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36534265
6.
Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claimsbased retrospective cohort study.
J Med Econ
; 26(1): 862-870, 2023.
Article
in English
| MEDLINE | ID: mdl-37350423
7.
Understanding the Burdens Associated with Huntington's Disease in Manifest Patients and Care Partners-Comparing to Parkinson's Disease and the General Population.
Brain Sci
; 12(2)2022 Jan 26.
Article
in English
| MEDLINE | ID: mdl-35203927
8.
Health care resource utilization and costs among individuals with vs without Huntington disease in a US population.
J Manag Care Spec Pharm
; 28(11): 1228-1239, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36282937
9.
Healthcare resource utilization and costs in individuals with Huntington's disease by disease stage in a US population.
J Med Econ
; 25(1): 722-729, 2022.
Article
in English
| MEDLINE | ID: mdl-35608039
10.
Estimating the risk of thrombotic events in people with congenital hemophilia A using US claims data.
J Comp Eff Res
; 10(18): 1323-1336, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34676773
11.
Real-world treatment, clinical outcomes and healthcare resource utilization among persons with hemophilia A by age.
J Comp Eff Res
; 10(15): 1121-1131, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34240615
12.
Healthcare utilization and cost burden of Huntington's disease among Medicare beneficiaries in the United States.
J Med Econ
; 24(1): 1327-1336, 2021.
Article
in English
| MEDLINE | ID: mdl-34730477
13.
Variation in access to hemophilia A treatments in the United States.
J Med Econ
; 24(1): 1143-1148, 2021.
Article
in English
| MEDLINE | ID: mdl-34538215
14.
Economic burden of pediatric prescription opioid poisonings in the United States.
J Manag Care Spec Pharm
; 27(1): 16-26, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33377438
15.
Model of Short- and Long-Term Outcomes of Emicizumab Prophylaxis Treatment for Persons with Hemophilia A.
J Manag Care Spec Pharm
; 26(9): 1109-1120, 2020 Sep.
Article
in English
| MEDLINE | ID: mdl-32452276
16.
Economic impact model of delayed inhibitor development in patients with hemophilia a receiving emicizumab for the prevention of bleeding events.
J Med Econ
; 22(12): 1328-1337, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-31530050
17.
A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries.
J Manag Care Spec Pharm
; 24(4): 317-326, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29578855
18.
Prescription opioid abuse: a literature review of the clinical and economic burden in the United States.
Popul Health Manag
; 17(6): 372-87, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25075734
19.
Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR.
Am Health Drug Benefits
; 6(9): 567-75, 2013 Nov.
Article
in English
| MEDLINE | ID: mdl-24991383
Results
1 -
19
de 19
1
Next >
>>